Eli Lilly settles Zyprexa case with 32 states & DC, to pay $62 million
Friday, October 10, 2008 10:00 IST Indianapolis, Indiana
Eli Lilly and Company announced that it has resolved a multi-state investigation involving 32 states and the District of Columbia (DC) related to the sales, marketing and promotion of its antipsychotic medication Zyprexa (olanzapine).
